Results at 68 weeks: 40.4% of CagriSema participants lost 25% or more of their body weight 91.9% lost at least 5% Blood pressure fell by 10.9 mmHg systolic on average About 40% of participants reduced or stopped blood pressure medications 87.7% of those with prediabetes at baseline achieved normal blood sugar Results were published in the New England Journal of Medicine and presented at the American Diabetes Associations 2026 Scientific Sessions
Accessed April 12, 2026
Resiliencey by having multiple suppliers is not incentivised because you split volumes and lose economies of scale. In response, Novo has lowered its prices in India, and has also licensed Emcure Pharmaceuticals to market semaglutide injections in India, priced midway between the emerging generics and Novos branded medicines
For researchers comparing these results with other medications, our guides on retatrutide vs semaglutide and the retatrutide vs tirzepatide dosage comparison provide detailed head-to-head analyses
For people living with rheumatoid arthritis, psoriatic arthritis, osteoarthritis, lupus, and gout, that has real implications
However, when the body is subjected to severe viral infections, environmental toxins, or chronic inflammation, this ratio can plummet dramatically, indicating that the cellular defense systems are overwhelmed and failing to keep pace with the influx of free radicals